These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22566701)

  • 21. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk.
    Marinigh R; Lane DA; Lip GY
    J Am Coll Cardiol; 2011 Mar; 57(12):1339-48. PubMed ID: 21414530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.
    Marrs JC; Saseen JJ
    Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of cardiovascular risk factors in chronic renal disease.
    Coresh J; Longenecker JC; Miller ER; Young HJ; Klag MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S24-30. PubMed ID: 11443765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
    G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
    Kessler M; Zannad F; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P;
    Nephrol Dial Transplant; 2007 Dec; 22(12):3573-9. PubMed ID: 17611249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [When to start dialysis. The predialysis patient].
    Triolo G; Savoldi S
    G Ital Nefrol; 2008; 25 Suppl 41():S9-12, discussion S13-20. PubMed ID: 18473314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment.
    Tsimihodimos V; Dounousi E; Siamopoulos KC
    Am J Nephrol; 2008; 28(6):958-73. PubMed ID: 18612199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary artery disease in chronic kidney disease patients: assessing the evidence for diagnosis, screening and revascularization.
    Saw J; Levin A; Gin K
    Can J Cardiol; 2004 Jun; 20(8):807-13. PubMed ID: 15229763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.
    Chiu YL; Chien KL; Lin SL; Chen YM; Tsai TJ; Wu KD
    Nephron Clin Pract; 2008; 109(3):c109-18. PubMed ID: 18663322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic kidney disease and cardiovascular disease--using the ANNA Standards and Practice Guidelines to improve care. Part 1: the epidemiology of chronic kidney disease: the risk factors and complications that contribute to cardiovascular disease.
    McCarley PB; Burrows-Hudson S
    Nephrol Nurs J; 2006; 33(6):666-74; quiz 675-6. PubMed ID: 17219728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between blood pressure and mortality in ESRD-not different from the general population?
    Lacson E; Lazarus JM
    Semin Dial; 2007; 20(6):510-7. PubMed ID: 17991196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbamylated low-density lipoprotein: nontraditional risk factor for cardiovascular events in patients with chronic kidney disease.
    Apostolov EO; Basnakian AG; Ok E; Shah SV
    J Ren Nutr; 2012 Jan; 22(1):134-8. PubMed ID: 22200430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of sympathetic nervous activity in renal injury and end-stage renal disease.
    Masuo K; Lambert GW; Esler MD; Rakugi H; Ogihara T; Schlaich MP
    Hypertens Res; 2010 Jun; 33(6):521-8. PubMed ID: 20339374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart failure in patients with chronic kidney disease.
    Lisowska A; Musiał WJ
    Rocz Akad Med Bialymst; 2004; 49():162-5. PubMed ID: 15631334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A; Makusidi AM; Kolo PM
    Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.